Jenni Björnulfson
Directeur Général chez LIDDS AB
Postes actifs de Jenni Björnulfson
Sociétés | Poste | Début | Fin |
---|---|---|---|
GHP SPECIALTY CARE AB (PUBL) | Corporate Officer/Principal | - | - |
LIDDS AB | Directeur Général | 01/12/2023 | - |
Directeur Financier/CFO | 01/12/2021 | - | |
Investor Relations Contact | 01/12/2021 | - | |
The C Story AB | Directeur/Membre du Conseil | - | - |
Cinclus Pharma Holding AB
Cinclus Pharma Holding AB BiotechnologyHealth Technology Cinclus Pharma Holding AB is a Swedish pharmaceutical company that focuses on developing clinical stage drug candidates for gastric acid related diseases. The company's drug candidate, linaprazan glurate, takes a new approach to provide improved management of GERD. Gastroesophageal reflux disease, or acid reflux, is a condition in which the content of the stomach regurgitates into the esophagus. The company was founded by pioneers in GERD treatment with extensive experience from Astra and Astra Zeneca. Christer Ahlberg has been the CEO of the company since 2021. | Directeur Financier/CFO | - | - |
Historique de carrière de Jenni Björnulfson
Anciens postes connus de Jenni Björnulfson
Sociétés | Poste | Début | Fin |
---|---|---|---|
Promore Pharma AB
Promore Pharma AB BiotechnologyHealth Technology Promore Pharma AB is a biopharmaceutical company, which engages in the development of therapeutic peptides for the bioactive wound care market. The company was founded by Mona Ståhle and Johan Heilborn on January 29, 2003 and is headquartered in Solna, Sweden. | Directeur Financier/CFO | 01/01/2016 | 25/08/2020 |
Investor Relations Contact | 01/01/2016 | 25/08/2020 | |
BIO VITOS PHARMA AB | Directeur/Membre du Conseil | 01/01/2016 | - |
Independent Dir/Board Member | 01/01/2016 | - |
Formation de Jenni Björnulfson
Karolinska Institutet | Undergraduate Degree |
Stockholm School of Economics | Graduate Degree |
Statistiques
Internationale
Suède | 9 |
Opérationnelle
Director of Finance/CFO | 3 |
Director/Board Member | 2 |
Investor Relations Contact | 2 |
Sectorielle
Health Technology | 5 |
Consumer Services | 3 |
Health Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
LIDDS AB | Health Technology |
BIO VITOS PHARMA AB | Health Technology |
Entreprise privées | 4 |
---|---|
GHP Specialty Care AB
GHP Specialty Care AB Medical/Nursing ServicesHealth Services GHP Specialty Care AB engages in the provision of healthcare services. It operates business through the Nordic Region and Rest of the World segments. The Nordic Region segment conducts business within specialist care, such as spine surgery/spine care, orthopaedics, obesity surgery and diabetes care, gastroenterology, urology, gynaecology, general surgery, arrhythmia, maternal health care, plastic surgery, and specialist dentistry. The Rest of the World segment manages business in the field of diabetes care at one clinic in the United Arab Emirates. The company was founded by Per Båtelson and Johan Wachtmeister in 2006 and is headquartered in Göteborg, Sweden. | Health Services |
Promore Pharma AB
Promore Pharma AB BiotechnologyHealth Technology Promore Pharma AB is a biopharmaceutical company, which engages in the development of therapeutic peptides for the bioactive wound care market. The company was founded by Mona Ståhle and Johan Heilborn on January 29, 2003 and is headquartered in Solna, Sweden. | Health Technology |
Cinclus Pharma Holding AB
Cinclus Pharma Holding AB BiotechnologyHealth Technology Cinclus Pharma Holding AB is a Swedish pharmaceutical company that focuses on developing clinical stage drug candidates for gastric acid related diseases. The company's drug candidate, linaprazan glurate, takes a new approach to provide improved management of GERD. Gastroesophageal reflux disease, or acid reflux, is a condition in which the content of the stomach regurgitates into the esophagus. The company was founded by pioneers in GERD treatment with extensive experience from Astra and Astra Zeneca. Christer Ahlberg has been the CEO of the company since 2021. | Health Technology |
The C Story AB |
- Bourse
- Insiders
- Jenni Björnulfson
- Expérience